Kapitał Pożyczkowy Zmiana Data
Acadia Pharmaceuticals USD 0 0 2025-03
Agios Pharmaceuticals USD 1.06M 0 2022-09
Alnylam Pharmaceuticals USD 2.11B 358.58M 2026-09
Amgen USD 51.61B 250M 2026-09
BioCryst Pharmaceuticals USD 395.61M 209K 2026-09
Biogen USD 7.29B 1.7M 2026-09
BioMarin Pharmaceutical USD 3.51B 12.96M 2026-09
Capricor Therapeutics USD 3.38M 0 2025-03
Daiichi Sankyo JPY 499.93B 75M 2026-09
Eli Lilly USD 46.99B 872M 2026-09
Gilead Sciences USD 23.82B 17M 2026-09
Incyte USD 28.42M 994K 2026-06
Insmed USD 544.86M 1.35M 2026-09
Ionis Pharmaceuticals USD 1.77B 140.62M 2026-09
Moderna USD 3.55B 2.95B 2026-09
Nektar Therapeutics USD 60.27M 2.89M 2026-03
Neurocrine Biosciences USD 169.5M 500K 2023-03
Novavax USD 246.3M 200K 2025-12
Pfizer USD 60B 498M 2026-09
PTC Therapeutics USD 536.27M 749K 2026-09
Regeneron Pharmaceuticals USD 1.99B 400K 2026-09
Roche Holding CHF 25.22B 2.21B 2026-06
Sangamo BioSciences USD 0 0 2022-06
Sanofi EUR 16.28B 1.63B 2026-09
Sarepta Therapeutics USD 699.39M 148.23M 2026-09
Tectonic Therapeutic USD 17K 26K 2026-03
Ultragenyx Pharmaceutical USD 1.13B 2M 2026-06
Vertex Pharmaceuticals USD 3.5B 3.39B 2026-09